Search Results 521-530 of 17981 for Hepatitis b

  1. A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C - Mayo Clinic

    Co-infection with HIV or Hepatitis B (defined as HBsAg-positive) at screening; Use of mTOR inhibitors (everolimus or sirolimus) in the 6 months prior to ...

  2. Baricitinib (oral route) - Side effects & dosage - Mayo Clinic

    May make these conditions worse. Heart or blood vessel disease or; Hepatitis B, history of or; Hepatitis C, history of or; Herpes zoster infection or ...

  3. Wilson's disease - Doctors and departments - Mayo Clinic

    ... Hepatitis B, Portal hypertension, Hemo...chromatosis, Alcoholic hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary ...

  4. https://www.mayoclinic.org/patient_consumer_drug.xml

    ... b-injection-route/description/drg-20061201</loc><lastmod>2024-02-11T22:30:54 ... hepatitis-b-and-polio-vaccine-intramuscular-route/description/drg ...

  5. Trial of Obeticholic Acid in Patients with Moderately Severe Alcoholic Hepatitis (AH) - Mayo Clinic

    The researchers suspect that individuals with alcoholic hepatitis have certain abnormalities in how their body handles bile acids (a product made by the liver ...

  6. Science Saturday: Saving time, lives and resources with new genetic testing treatment

    Among China's high-risk population, 87 million people are hepatitis B virus carriers, an affliction that significantly elevates their risk of developing liver ...

  7. Dolutegravir and lamivudine (oral route) - Mayo Clinic

    Hepatitis B or C infection—Use with caution. May make this condition worse. Kidney disease or; Liver disease, severe—Use is not recommended in patients with ...

  8. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Granulomatosis polyangiitis—Use with caution. May increase the chance of getting new cancers. Diabetes or; Hepatitis B, history of or; Opportunistic infections, ...

  9. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    Known central nervous system (CNS) lymphoma · History of interstitial lung disease, prior malignancy, active autoimmune disease, positive test for hepatitis B or ...

  10. Canakinumab (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hepatitis B, history of or; Hepatitis C, history of or; Immune system problem (eg, HIV or AIDS) or; Infection, active or history of or; Tuberculosis, active ...